Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBR 3464 in Metastatic Small Cell Lung Cancer
NCT00014547Phase 2Unknown
- Sponsor
- Theradex Oncology
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triplatin in small cell lung cancer (SCLC), sponsored by Theradex Oncology. Status: unknown.
02
Drugs
triplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00014547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014547.